In this latest rapid-reference memory aid, Helen O’Neil summarises the dosing, contraindications, and adverse events of drugs for painful neuropathy, along with treatment pathways and advice on switching from gabapentin to pregabalin. Readers are directed to the PDF version of the article.
Early data from the NHS Type 2 Diabetes Path to Remission programme show it is effective in achieving remission at scale outside of clinical trials.
3 Sep 2024